IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2019

Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma. E. SPARTALIS, D.I. ATHANASIADIS, D. CHRYSIKOS, M. SPARTALIS, G. BOUTZIOS, D. SCHIZAS, N. GARMPIS, C. DAMASKOS, S.A. PASCHOU, A. IOANNIDIS, G. TSOUROUFLIS, D. DIMITROULIS, N.I. NIKITEAS (Athens; Thessaloniki, Greece). Anticancer Res 39:1119-1127, 2019.
Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling. I. VASYUTIN, L. ZERIHUN, C. IVAN, A. ATALA (Moscow, Russia; New York, NY; Winston-Salem, NC, USA). Anticancer Res 39:1105-1118, 2019.
GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review. K. SYRJÄNEN, M. ESKELINEN, A. PEETSALU, T. SILLAKIVI, P. SIPPONEN, M. HÄRKÖNEN, L. PALOHEIMO, M. MÄKI, T. TIUSANEN, O. SUOVANIEMI, F. DiMARIO, Z.P. FAN (Helsinki; Kuopio; Espoo, Finland; Barretos, Brazil; Tartu, Estonia; Parma, Italy; Shanghai, PR China). Anticancer Res 39:1091-1104, 2019.
Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer. N. AKSORN, P. CHANVORACHOTE (Bangkok, Thailand). Anticancer Res 39:541-548, 2019.
The Role of KRAS in Endometrial Cancer: A Mini-Review. M. SIDERIS, E.I. EMIN, Z. ABDULLAH, J. HANRAHAN, K.M. STEFATOU, V. SEVAS, E. EMIN, T. HOLLINGWORTH, F. ODEJINMI, S. PAPAGRIGORIADIS, S. VIMPLIS, F. WILLMOTT (London, UK; Patras; Ioannina; Athens, Greece). Anticancer Res 39:533-539, 2019.
MicroRNA-based Targeted Therapeutics in Pancreatic Cancer. N. GURBUZ, B. OZPOLAT (Isparta, Turkey; Houston, TX, USA). Anticancer Res 39:529-532, 2019.
Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges. M. SEDIĆ, P. GRBČIĆ, S. KRALJEVIĆ PAVELIĆ (Rijeka, Croatia). Anticancer Res 39:41-56, 2019.
MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma. A. ZEMBSKA, A. JAWIARCZYK-PRZYBYŁOWSKA, B. WOJTCZAK, M. BOLANOWSKI (Wroclaw, Poland). Anticancer Res 39:33-40, 2019.
Anticoagulant Therapy for Disseminated Intravascular Coagulation After Gastrointestinal Surgery. D. HASHIMOTO, T. OKAWA, R. MARUYAMA, F. MATSUMURA, Y. SHIBATA, H. KOHROGI (Kumamoto; Omuta, Japan). Anticancer Res 39:25-31, 2019.
An Update on the Current Role of High Resolution Anoscopy in Patients With Anal Dysplasia. A. GUDUR, D. SHANMUGANANDAMURTHY, Z. SZEP, J.L. POGGIO (Philadelphia, PA, USA). Anticancer Res 39:17-23, 2019.
Evolution of Cancer Progression in the Context of Darwinism. L. LACINA, M. ČOMA, B. DVOŘÁNKOVÁ, O. KODET, N. MELEGOVÁ, P. GÁL, K. SMETANA JR (Prague; Vestec, Czech Republic; Košice; Bratislava, Slovak Republic). Anticancer Res 39:1-16, 2019.
Does Transdermal Testosterone Increase the Risk of Developing Breast Cancer? A Systematic Review. R. GERA, S. TAYEH, H. EL-HAGE CHEHADE, K. MOKBEL (London, UK). Anticancer Res 38:6615-6620, 2018.
Application of Artificial Intelligence-based Technology in Cancer Management: A Commentary on the Deployment of Artificial Neural Networks. G.V. SHERBET, W.L. WOO, S. DLAY (Huntington Beach, CA, USA; Newcastle upon Tyne, UK). Anticancer Res 38:6607-6613, 2018.
Targeted Therapies for Pancreatic Cancer and Hurdles Ahead. M. ASLAN, R. SHAHBAZI, K. ULUBAYRAM, B. OZPOLAT (Ankara, Turkey; Houston, TX, USA). Anticancer Res 38:6591-6606, 2018.
Collision Tumors of the Gastrointestinal Tract: A Systematic Review of the Literature. D. SCHIZAS, I. KATSAROS, A. MICHALINOS, C. DAMASKOS, N. GARMPIS, V. NTOMI, G. AGROGIANNIS, S. STERGIOPOULOS, A.K. TSAROUCHA (Athens; Alexandroupolis, Greece). Anticancer Res 38:6047-6057, 2018.
Technical Advances in Radiation Therapy for Brain Tumors. C. SCARINGI, L. AGOLLI, G. MINNITI (Rome; Pozzilli, Italy; Dresden, Germany). Anticancer Res 38:6041-6045, 2018.
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC. S. GIACINTI, G. POTI, M. ROBERTO, S. MACRINI, M. BASSANELLI, F. DI PIETRO, A.M. ASCHELTER, A. CERIBELLI, E.M. RUGGERI, P. MARCHETTI (Viterbo; Rome; Rieti, Italy). Anticancer Res 38:6029-6039, 2018.
Spinal Ewing Sarcoma Debuting with Cord Compression: Have We Discovered the Thread of Ariadne? S. BOUSSIOS, C. HAYWARD, D. COOKE, N. ZAKYNTHINAKIS-KYRIAKOU, A.K. TSIOURIS, A.A. CHATZIANTONIOU, F.S. KANELLOS, A. KARATHANASI (Kent; Leicester, UK; Ioannina, Greece). Anticancer Res 38:5589-5597, 2018.
Surgical Endoscopic Vacuum-assisted Closure Therapy (EVAC) in Treating Anastomotic Leakages After Major Resective Surgery of Esophageal and Gastric Cancer. E. VIRGILIO, D. CECI, M. CAVALLINI (Rome, Italy). Anticancer Res 38:5581-5587, 2018.
Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer. R. PARK, S. WILLIAMSON, A. KASI, A. SAEED (Seoul, Republic of Korea; Kansas City, KS, USA). Anticancer Res 38:5569-5580, 2018.
Radiation-induced Demyelination and Remyelination in the Central Nervous System: A Literature Review. L. HELSON (East Winsdor, NJ, USA). Anticancer Res 38:4999-5002, 2018.
Metastatic Spinal Cord Compression: Unraveling the Diagnostic and Therapeutic Challenges. S. BOUSSIOS, D. COOKE, C. HAYWARD, F.S. KANELLOS, A.K. TSIOURIS, A.A. CHATZIANTONIOU, N. ZAKYNTHINAKIS-KYRIAKOU, A. KARATHANASI (Kent; Leicester, UK; Ioannina, Greece). Anticancer Res 38:4987-4998, 2018.
Whole Lung Irradiation in Patients with Osteosarcoma and Ewing Sarcoma. L. RONCHI, M. BUWENGE, A. CORTESI, I. AMMENDOLIA, R. FRAKULLI, M.E. ABATE, A. ARCELLI, C.M. DONATI, G. MACCHIA, A.G. MORGANTI, S. CAMMELLI (Bologna; Meldola; Campobasso, Italy). Anticancer Res 38:4977-4986, 2018.
Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer. R.L. MILLETT, J.M. ELKON, I.A. TABBARA (Washington, DC, USA). Anticancer Res 38:4969-4976, 2018.
Relationship Between Metabolic Disorders and Breast Cancer Incidence and Outcomes. Is There a Preventive and Therapeutic Role for Berberine? M. CAZZANIGA, B. BONANNI (Milan, Italy). Anticancer Res 38:4393-4402, 2018.
Contribution of Computed Tomographic Angiography to Pretreatment Planning of Radio-embolization of Liver Tumors. H. MIRKA, P. DURAS, J. BAXA, E. KORCAKOVA, J. FERDA (Pilsen, Czech Republic). Anticancer Res 38:3825-3829, 2018.
The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence. M.M. MOSCHOS, M. DETTORAKI, S. ANDROUDI, D. KALOGEROPOULOS, A. LAVARIS, N. GARMPIS, C. DAMASKOS, A. GARMPI, M. TSATSOS (Athens; Larissa; Ioannina, Greece; Birmingham, UK). Anticancer Res 38:3817-3824, 2018.
Severe Defects in the Macrophage Barrier to Gut Microflora in Inflammatory Bowel Disease and Colon Cancer. C.A. RUBIO, P.T. SCHMIDT (Stockholm, Sweden). Anticancer Res 38:3811-3815, 2018.
Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds. A. MAIUTHED, W. CHANTARAWONG, P. CHANVORACHOTE (Bangkok, Thailand). Anticancer Res 38:3797-3809, 2018.
Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC. M. BASSANELLI, S. SIOLETIC, M. MARTINI, S. GIACINTI, A. VITERBO, A. STADDON, F. LIBERATI, A. CERIBELLI (Rieti; Rome; Grosseto, Italy; Dublin, Ireland). Anticancer Res 38:3789-3796, 2018.
The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract. B. PÓSFAI, L. KUTHI, L. VARGA, I. LACZÓ, J. RÉVÉSZ, R. KRÁNICZ, A. MARÁZ (Szeged; Gyula; Miskolc, Hungary). Anticancer Res 38:3243-3254, 2018.
Multimodal Anti-tumor Approaches Combined with Ιmmunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer. L. BOLM, L. KÄSMANN, A. PAYSEN, C. KARAPETIS, D. RADES, U.F. WELLNER, T. KECK, D.I. WATSON, R. HUMMEL, D.J. HUSSEY (Luebeck, Germany; Bedford Park, Australia). Anticancer Res 38:3231-3242, 2018.
Potentially Malignant Oral Disorders and Cancer Transformation. D. GANESH, P. SREENIVASAN, J. ÖHMAN, M. WALLSTRÖM, P.H. BRAZ-SILVA, D. GIGLIO, G. KJELLER, B. HASSÉUS (Gothenburg, Sweden; Kerala, India; Sao Paulo, Brazil). Anticancer Res 38:3223-3230, 2018.
Dietary Patterns and Breast Cancer Risk: A Systematic Review. A. DANDAMUDI, J. TOMMIE, L. NOMMSEN-RIVERS, S. COUCH (Cincinnati, OH, USA). Anticancer Res 38:3209-3222, 2018.
Molecular Mechanisms of Breast Cancer Metastasis and Potential Anti-metastatic Compounds. S. TUNGSUKRUTHAI, N. PETPIROON, P. CHANVORACHOTE (Bangkok, Thailand). Anticancer Res 38:2607-2618, 2018.
Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances. S. NASSEREDDINE, S. ALSUBAIT, I. TABBARA (Washington, DC; Danbuty, CT, USA). Anticancer Res 38:2597-2606, 2018.
Laparoscopic Intragastric Surgery for Treating Early Gastric Cancer. E. VIRGILIO, G. BALDUCCI, P. MERCANTINI, E. GIARNIERI, M.R. GIOVAGNOLI, M. MONTAGNINI, A. PROIETTI, R. D’URSO, M. CAVALLINI (Rome, Italy). Anticancer Res 38:1911-1916, 2018.
Clinicopathological and Molecular Factors, Risk Factors, Treatment Outcomes and Risk of Recurrence in Mesenteric and Retroperitoneal Extragastrointestinal Stromal Tumors. K.G. APOSTOLOU, D. SCHIZAS, E. VAVOURAKI, A. MICHALINOS, D.I. TSILIMIGRAS, N. GARMPIS, C. DAMASKOS, A. PAPALAMPROS, T. LIAKAKOS (Athens, Greece). Anticancer Res 38:1903-1909, 2018.
Aspirin in the Management of Patients with Prostate Cancer Undergoing Radiotherapy: Friend or Foe? B. MASCAN, L. MARIGNOL (Dublin, Ireland). Anticancer Res 38:1897-1902, 2018.
Radiotherapy May Offer a Recurrence and Survival Benefit in Rectal Cancers Treated Surgically with Transanal Endoscopic Microsurgery: A Systematic Review and Meta-analysis. M. SIDERIS, A.N. DONALDSON, J. HANRAHAN, M. GRUNWALD, S. PAPAGRIGORIADIS (London, UK; New York, NY, USA; Athens, Greece). Anticancer Res 38:1879-1895, 2018.
Molecular Sequence of Events and Signaling Pathways in Cerebral Metastases. J.B. COOPER, J.S. RONECKER, M.E. TOBIAS, A.L. MOHAN, V. HILLARD, R. MURALI, C.D. GANDHI, M.H. SCHMIDT, M. JHANWAR-UNIYAL (Valhalla, NY, USA). Anticancer Res 38:1859-1877, 2018.
Visualizing the Tumor Microenvironment by Color-coded Imaging in Orthotopic Mouse Models of Cancer. A. SUETSUGU, M. SHIMIZU, S. SAJI, H. MORIWAKI, R.M. HOFFMAN (Gifu, Japan; San Diego, CA, USA). Anticancer Res 38:1847-1857, 2018.
Update on Surgical Management of Small Bowel Neuroendocrine Tumors. D. MORIS, I. NTANASIS-STATHOPOULOS, D.I. TSILIMIGRAS, S. VAGIOS, A. KARAMITROS, G. KARAOLANIS, J. GRINIATSOS, A. PAPALAMPROS, I. PAPACONSTANTINOU, G.K. GLANTZOUNIS, E. SPARTALIS, D.G. BLAZER 3rd, E. FELEKOURAS (Durham, NC, USA; Athens; Ioannina, Greece). Anticancer Res 38:1267-1278, 2018.
Is Adjuvant Endocrine Therapy Indicated for DCIS Patients After Complete Surgical Excision? H. EL HAGE CHEHADE, K. MOKBEL (London, UK). Anticancer Res 38:1263-1266, 2018.
Gastric Cancer Cells in Peritoneal Lavage Fluid: A Systematic Review Comparing Cytological with Molecular Detection for Diagnosis of Peritoneal Metastases and Prediction of Peritoneal Recurrences. E. VIRGILIO, E. GIARNIERI, M.R. GIOVAGNOLI, M. MONTAGNINI, A. PROIETTI, R. D’URSO, P. MERCANTINI, S. VALABREGA, G. BALDUCCI, M. CAVALLINI (Rome, Italy). Anticancer Res 38:1255-1262, 2018.
Radiation Therapy for Angiosarcoma of the Scalp: Total Scalp Irradiation and Local Irradiation. M. HATA (Yokohama, Japan). Anticancer Res 38:1247-1254, 2018.
Centrosomal Abnormalities in Pancreatic Cancer: Molecular Mechanisms and Clinical Implications. D. ANSARI, C. DEL PINO BELLIDO, M. BAUDEN, R. ANDERSSON (Lund, Sweden). Anticancer Res 38:1241-1246, 2018.
Stereotactic Body Radiation Therapy for Patients with Early-stage Prostate Cancer. H. LINNEY, S. BARRETT (Dublin, Ireland). Anticancer Res 38:1231-1240, 2018.
Postoperative Hypofractionated Radiation Therapy in Prostate Carcinoma: A Systematic Review. G. SIEPE, M. BUWENGE, N.P. NGUYEN, G. MACCHIA, F. DEODATO, S. CILLA, G.C. MATTIUCCI, I. CAPOCACCIA, S. CAMMELLI, A. GUIDO, A. ARCELLI, M. NTRETA, S. GUERRI, A.G. MORGANTI (Bologna; Campobasso; Rome, Italy; Washington, DC, USA). Anticancer Res 38:1221-1230, 2018.
Dual Role of Mitophagy in Cancer Drug Resistance. C. YAN, T.-S. LI (Sakamoto, Japan). Anticancer Res 38:617-622, 2018.
Page: 1 2 3 4 5 6 ... 8 9 10 11 12 13 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system